Century Capital Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Century Capital Management’s Portfolio EGRX Stock Details EGRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-85,069	Closed	-$3.44M	–	216
2016 Q1	$3.44M	Buy	85,069 +18,860	+28%	+$1.2M	0.38%	126
2015 Q4	$5.87M	Buy	66,209 +16,942	+34%	+$1.34M	0.34%	95
2015 Q3	$3.65M	Sell	49,267 -27,432	-36%	-$2.28M	0.21%	151
2015 Q2	$6.2M	Buy	+76,699	New	+$5M	0.35%	90

Other funds holding EGRX

PAI

ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

HEC

Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

JAM

JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Century Capital Management's EGRX Position: Q2 2016 in Review

Century Capital Management sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q2 2016, closing a stake of 85,069 shares — an estimated $3.44M sold.

Century Capital Management first reported a position in EGRX in Q2 2015 and held it in 4 quarters. The position peaked at $6.2M in Q2 2015. 116 funds tracked by Wall St. Rank hold EGRX as of Q2 2016.

Century Capital Management reported no remaining Eagle Pharmaceuticals, Inc. position as of Q2 2016 after selling out during the quarter.
Century Capital Management sold 85,069 Eagle Pharmaceuticals, Inc. shares in Q2 2016, an estimated $3.44M.
Century Capital Management first reported a position in Eagle Pharmaceuticals, Inc. in Q2 2015 and held it in 4 quarters.
Century Capital Management's Eagle Pharmaceuticals, Inc. position peaked at $6.2M in Q2 2015.
116 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q2 2016.

Based on Century Capital Management's 13F filing for Q2 2016, filed 10 Aug 2016.